谄媚于人 发表于 2025-3-25 06:05:35

Submitted on: 26 October 2019.
Revised on: 21 November 2019.
Accepted on: 22 December 2019.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER

CHASE 发表于 2025-3-25 09:39:59

Submitted on: 22 August 2001.
Revised on: 18 December 2001.
Accepted on: 10 January 2002.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER

新字 发表于 2025-3-25 14:21:22

Submitted on: 03 August 2017.
Revised on: 01 October 2017.
Accepted on: 08 November 2017.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER

搏斗 发表于 2025-3-25 16:00:49

Submitted on: 15 April 2014.
Revised on: 08 June 2014.
Accepted on: 05 August 2014.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER

断断续续 发表于 2025-3-25 22:41:17

Submitted on: 14 December 2012.
Revised on: 16 January 2013.
Accepted on: 23 February 2013.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER

Carcinoma 发表于 2025-3-26 02:40:25

Submitted on: 02 November 2004.
Revised on: 10 January 2005.
Accepted on: 27 February 2005.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER

incontinence 发表于 2025-3-26 04:44:52

Submitted on: 01 January 2003.
Revised on: 23 January 2003.
Accepted on: 28 February 2003.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER

异常 发表于 2025-3-26 11:09:55

http://reply.papertrans.cn/2/146/14536/14536-28.png

intention 发表于 2025-3-26 16:22:26

Submitted on: 07 August 2018.
Revised on: 01 October 2018.
Accepted on: 19 October 2018.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER

制造 发表于 2025-3-26 17:12:36

Submitted on: 04 April 2010.
Revised on: 29 June 2010.
Accepted on: 12 August 2010.

___________________INVESTIGATIONAL NEW DRUGS---SPRINGER
页: 1 2 [3] 4
查看完整版本: SCIE期刊INVESTIGATIONAL NEW DRUGS 2024/2025影响因子:3.161 (INVEST NEW DRUG) (0167-6997). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sci